SG83723A1 - Novel therapeutic agents that modulate 5ht receptors - Google Patents

Novel therapeutic agents that modulate 5ht receptors

Info

Publication number
SG83723A1
SG83723A1 SG9902842A SG1999002842A SG83723A1 SG 83723 A1 SG83723 A1 SG 83723A1 SG 9902842 A SG9902842 A SG 9902842A SG 1999002842 A SG1999002842 A SG 1999002842A SG 83723 A1 SG83723 A1 SG 83723A1
Authority
SG
Singapore
Prior art keywords
modulate
receptors
therapeutic agents
novel therapeutic
novel
Prior art date
Application number
SG9902842A
Inventor
Marquess Daniel
Choi Seok-Ki
H Griffin John
Original Assignee
Advanced Medicine Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Medicine Inc filed Critical Advanced Medicine Inc
Publication of SG83723A1 publication Critical patent/SG83723A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0446—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/545—Heterocyclic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG9902842A 1998-06-08 1999-06-08 Novel therapeutic agents that modulate 5ht receptors SG83723A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8846698P 1998-06-08 1998-06-08
US9293898P 1998-07-15 1998-07-15
US9660698P 1998-08-14 1998-08-14

Publications (1)

Publication Number Publication Date
SG83723A1 true SG83723A1 (en) 2001-10-16

Family

ID=27375972

Family Applications (1)

Application Number Title Priority Date Filing Date
SG9902842A SG83723A1 (en) 1998-06-08 1999-06-08 Novel therapeutic agents that modulate 5ht receptors

Country Status (6)

Country Link
EP (1) EP1083918A1 (en)
AR (1) AR019631A1 (en)
AU (1) AU4425399A (en)
CA (1) CA2319174A1 (en)
SG (1) SG83723A1 (en)
WO (1) WO1999064044A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9903996D0 (en) * 1999-11-03 1999-11-03 Astra Ab New compounds
DE10037310A1 (en) 2000-07-28 2002-02-07 Asta Medica Ag New indole derivatives and their use as medicines
US6444477B1 (en) * 2000-11-28 2002-09-03 Pharmagene Laboratories Limited Assay method for detecting 5-HT2B antagonists
AU2002230057A1 (en) * 2001-01-29 2002-08-12 Insight Strategy And Marketing Ltd Diphenyl ether derivatives and their uses as heparanase inhibitors
WO2004054581A2 (en) * 2002-12-13 2004-07-01 Smithkline Beecham Corporation Cyclohexyl compounds as ccr5 antagonists
CN102060806A (en) 2003-09-11 2011-05-18 iTherX药品公司 Cytokine inhibitors
US7381732B2 (en) 2004-10-26 2008-06-03 Bristol-Myers Squibb Company Pyrazolobenzamides and derivatives as factor Xa inhibitors
WO2010123139A1 (en) * 2009-04-24 2010-10-28 持田製薬株式会社 Arylcarboxamide derivative having sulfamoyl group
WO2015015378A2 (en) * 2013-08-02 2015-02-05 Pfizer Inc. Rorc2 inhibitors and methods of use thereof
US10485789B2 (en) 2014-07-24 2019-11-26 Sensor Pharmaceuticals, Inc. Compositions and methods for targeting receptors expressed in the gut
CN105439914B (en) * 2014-09-17 2017-07-11 复旦大学 4 aminoacyl phenoxy acetamide class compounds and its medicinal usage
JP2018510131A (en) 2015-01-30 2018-04-12 ファイザー・インク RORC2 sulfonamide substituted indole modulator and method of use thereof
WO2016120849A1 (en) 2015-01-30 2016-08-04 Pfizer Inc. Methoxy-substituted pyrrolopyridine modulators of rorc2 and methods of use thereof
EP4208446A1 (en) * 2020-09-02 2023-07-12 Enveric Biosciences Canada Inc. Nitrated psilocybin derivatives and use thereof for modulating 5-ht2a receptor and for treating a psychiatric disorder
WO2023044556A1 (en) * 2021-09-24 2023-03-30 Enveric Biosciences Canada Inc. Aminated psilocybin derivatives and methods of using

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998003632A1 (en) * 1996-07-24 1998-01-29 Yale University Bivalent agonists for g-protein coupled receptors
WO1998011436A1 (en) * 1996-09-13 1998-03-19 Whitehead Institute For Biomedical Research Non-specific affinity enhancement to identify combinatorial library members
WO1998028293A1 (en) * 1996-12-20 1998-07-02 H.Lundbeck A/S Indane or dihydroindole derivatives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0510132B1 (en) * 1990-09-28 1997-05-14 Neorx Corporation Polymeric carriers for release of covalently linked agents
US5364856A (en) * 1991-03-28 1994-11-15 Eli Lilly And Company 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[CD]indoles
US5244912A (en) * 1991-03-28 1993-09-14 Eli Lilly And Company 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz(cd)indoles and pharmaceutical use thereof
FR2712591B1 (en) * 1993-11-19 1996-02-09 Pf Medicament New arylpiperazines derived from indole, their preparation and their therapeutic use.
GB9517559D0 (en) * 1995-08-26 1995-10-25 Smithkline Beecham Plc Novel compounds
AU2332497A (en) * 1996-03-19 1997-10-10 Salk Institute For Biological Studies, The (in vitro) methods for identifying modulators of members of the steroid/thyroid superfamily of receptors

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998003632A1 (en) * 1996-07-24 1998-01-29 Yale University Bivalent agonists for g-protein coupled receptors
WO1998011436A1 (en) * 1996-09-13 1998-03-19 Whitehead Institute For Biomedical Research Non-specific affinity enhancement to identify combinatorial library members
WO1998028293A1 (en) * 1996-12-20 1998-07-02 H.Lundbeck A/S Indane or dihydroindole derivatives

Also Published As

Publication number Publication date
CA2319174A1 (en) 1999-12-16
WO1999064044A1 (en) 1999-12-16
EP1083918A1 (en) 2001-03-21
AU4425399A (en) 1999-12-30
AR019631A1 (en) 2002-02-27

Similar Documents

Publication Publication Date Title
EP1080080A4 (en) Novel therapeutic agents that modulate neurokinin receptors
GB9708484D0 (en) Therapeutic agents
GB9816263D0 (en) Therapeutic agents
GB9708945D0 (en) Therapeutic agents
GB9806102D0 (en) Therapeutic agents
GB9704948D0 (en) Therapeutic agents
GB9702524D0 (en) Therapeutic agents
SG83723A1 (en) Novel therapeutic agents that modulate 5ht receptors
GB9826359D0 (en) Novel receptors
GB9808663D0 (en) Therapeutic agents
GB9801234D0 (en) Therapeutic agents
GB9813576D0 (en) Therapeutic agents
GB9813006D0 (en) Therapeutic agents
GB9801210D0 (en) Therapeutic agents
IL143385A0 (en) 5ht1 antagonists for antidepressant therapy
AP9901436A0 (en) Therapeutic agents
GB9801397D0 (en) Therapeutic agents
GB9702392D0 (en) Therapeutic agents
GB9801202D0 (en) Therapeutic agents
GB9700555D0 (en) Therapeutic agents
GB9819484D0 (en) Therapeutic agents
GB9810092D0 (en) Therapeutic agents
GB9811879D0 (en) Therapeutic agents
GB9815317D0 (en) Therapeutic agents
GB9805716D0 (en) Therapeutic agents